Abstract: Provided are a co-occurrence word data generating unit configured to generate co-occurrence word data including a co-occurrence word that is a vocabulary used along with a predetermined keyword in posted data in all periods and an appearance frequency of the co-occurrence word, from among pieces of posted data posed in a plurality of different periods; and a related data generating unit configured to generate related data including the co-occurrence word as a usual related word when a temporal variation in the appearance frequency of the co-occurrence word is smaller than a first threshold value and the appearance frequency is higher than a second threshold value.

Abstract: It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: wherein n is an integer of 0 or of 1 to 4; R1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by —OR2; R2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R3 is a protective group.

Abstract: It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: wherein n is an integer of 0 or of 1 to 4; R1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by —OR2; R2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R3 is a protective group.

Abstract: An exercise equipment exercise equipment that can readily switch arrangement of a person exercise apparatus and a dog exercise apparatus between the state where a person and a dog run facing each other and/or the state where the person and the dog run side by side. The person exercise apparatus includes a frame, a crank mechanism having a crank shaft rotatably supported by the frame, a crank coupled to the crank shaft, and a pedal rotatably supported by the crank, and a joint rotatingly driven by the crank mechanism. An annular travelling belt travels with a dog, a roller drives the travelling belt, and a transmission mechanism transmits rotational motion of the joint to the roller An input shaft is aligned with a rotary shaft of the joint with respect to a mounting face of the exercise equipment. A coupling mechanisms is detachably engageable with the joint at each end.

Abstract: Provided is a technology that allows use of a trend rating acquired more objectively. A POI information providing device includes: a storage unit which stores POI data including a POI name; a posted data acquisition unit which acquires posted data through a network; a trend rating acquisition unit which obtains a matching degree between a word included in the posted data and the POI name for each piece of the posted data, and uses a predetermined calculation expression for the matching degree to calculate and acquire a trend rating indicating an attention degree of a POI; a trend rating identification unit which identifies, when a request for the trend rating is received from another device connected through the network, the trend rating corresponding to the request; and a transmission unit which transmits the trend rating identified by the trend rating identification unit to the another device.

Abstract: To provide a biomarker which is a metabolite included in a biological sample, and which can be collected in a noninvasive method and detected in a convenient analysis method, and which varies according to progression of pathological conditions of irritable bowel syndrome (IBS). Furthermore, such biomarkers are useful for determination of the presence or absence of morbidity of IBS, determination of severity of IBS, determination of types of IBS, determination of necessity of treatment of IBS, and confirmation of drug efficacy of an IBS therapeutic agent.

Abstract: An exercise equipment exercise equipment that can readily switch arrangement of a person exercise apparatus and a dog exercise apparatus between the state where a person and a dog run facing each other and the state where the person and the dog run side by side. The person exercise apparatus includes a frame, a crank mechanism having a crank shaft rotatably supported by the frame, a crank coupled to the crank shaft, and a pedal rotatably supported by the crank, and a joint rotatingly driven by the crank mechanism. An annular travelling belt travels with a dog, a roller drives the travelling belt, and a transmission mechanism transmits rotational motion of the joint to the rollerAn input shaft is aligned with a rotary shaft of the joint with respect to a mounting face of the exercise equipment-A. coupling mechanisms is detachably engageable with the joint at each end.

Abstract: There is provided a slide fastener. A pair of core sections are respectively provided along opposing tape side edge portions of a pair of fastener tapes. A pair of fastener element rows are respectively attached to the pair of core sections. Each of the pair of fastener element rows includes a plurality of fastener elements made of metal. Silica is applied to surfaces of the core sections and the fastener elements.

Abstract: It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: wherein n is an integer of 0 or of 1 to 4; R1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by —OR2; R2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R3 is a protective group.

Abstract: It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: wherein n is an integer of 0 or of 1 to 4; R1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by —OR2; R2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R3 is a protective group.

Abstract: It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: wherein n is an integer of 0 or of 1 to 4; R1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by —OR2; R2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R3 is a protective group.

Abstract: The fastener stringer is arranged with at least one printable resin layer to which ink can be fixed on the entire surface of fastener elements. Printing by an inkjet method is carried out at least on the exposed surfaces exposed on the first tape surface side in the tape front- and back direction of the fastener elements, the inner surfaces of the first tape surface side facing the tape inward side, along with the first tape surface of the fastener tape. A desired pattern can thereby be stably formed not only on the fastener tape and the exposed surfaces of the fastener elements, but can also be formed on the inner surfaces of the fastener elements. Therefore, a pattern can be formed in a continuous manner on the fastener tape and the fastener elements, and decorativeness and design unattainable in the past can be obtained.

Abstract: It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: wherein n is an integer of 0 or of 1 to 4; R1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by —OR2; R2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R3 is a protective group.

Abstract: Provided are a co-occurrence word data generating unit configured to generate co-occurrence word data including a co-occurrence word that is a vocabulary used along with a predetermined keyword in posted data in all periods and an appearance frequency of the co-occurrence word, from among pieces of posted data posed in a plurality of different periods; and a related data generating unit configured to generate related data including the co-occurrence word as a usual related word when a temporal variation in the appearance frequency of the co-occurrence word is smaller than a first threshold value and the appearance frequency is higher than a second threshold value.

Abstract: There is provided a slide fastener. A pair of core sections are respectively provided along opposing tape side edge portions of a pair of fastener tapes. A pair of fastener element rows are respectively attached to the pair of core sections. Each of the pair of fastener element rows includes a plurality of fastener elements made of metal. Silica is applied to surfaces of the core sections and the fastener elements.

Abstract: Provided is a technology that allows use of a trend rating acquired more objectively. A POI information providing device includes: a storage unit which stores POI data including a POI name; a posted data acquisition unit which acquires posted data through a network; a trend rating acquisition unit which obtains a matching degree between a word included in the posted data and the POI name for each piece of the posted data, and uses a predetermined calculation expression for the matching degree to calculate and acquire a trend rating indicating an attention degree of a POI; a trend rating identification unit which identifies, when a request for the trend rating is received from another device connected through the network, the trend rating corresponding to the request; and a transmission unit which transmits the trend rating identified by the trend rating identification unit to the another device.

Abstract: The fastener stringer is arranged with at least one printable resin layer to which ink can be fixed on the entire surface of fastener elements. Printing by an inkjet method is carried out at least on the exposed surfaces exposed on the first tape surface side in the tape front- and back direction of the fastener elements, the inner surfaces of the first tape surface side facing the tape inward side, along with the first tape surface of the fastener tape. A desired pattern can thereby be stably formed not only on the fastener tape and the exposed surfaces of the fastener elements, but can also be formed on the inner surfaces of the fastener elements. Therefore, a pattern can be formed in a continuous manner on the fastener tape and the fastener elements, and decorativeness and design unattainable in the past can be obtained.

Abstract: It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: wherein n is an integer of 0 or of 1 to 4; R1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by —OR2; R2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R3 is a protective group.

Abstract: A composition including a radioactive fluorine-labeled amino acid compound is provided, which can be prevented from radiolysis. Disclosed is a composition which includes a solution containing a radioactive fluorine-labeled amino acid compound as an effective ingredient, in which the pH value of the solution is kept at 2.0-5.9, more preferably 2.0-4.9 in order to inhibit radiolysis. Also, it is possible to further inhibit radiolysis by adding thereto a pharmaceutical additive capable of inhibiting radiolysis, such as a sugar, a sugar alcohol and a sugar lactone, while the pH is kept at 2.0-5.9.

Abstract: It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: wherein n is an integer of 0 or of 1 to 4; R1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by —OR2; R2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R3 is a protective group.